Statement of Changes in Beneficial Ownership (4)
19 Noviembre 2014 - 4:44PM
Edgar (US Regulatory)
Exhibit 99
Form 4 Joint Filer Information
Names of Joint Filers:
Canaan VIII L.P.
Canaan Partners VIII LLC
Canaan Management, Inc.
Address of Joint Filers:
c/o Canaan Partners
285 Riverside Avenue, Suite 250
Westport, CT 06880
Designated Filer:
Canaan VIII L.P.
Issuer and Ticker Symbol:
Durata Therapeutics, Inc. [DRTX]
Date of Event:
November 17, 2014
Signatures of Joint Filers:
Canaan VIII L.P.
By: Canaan Partners VIII LLC
Its Sole General Partner
By: /s/ Jaime E. Slocum, Attorney-in-Fact
--------------------------------------
Manager
Canaan Partners VIII LLC
By: /s/ Jaime E. Slocum, Attorney-in-Fact
--------------------------------------
Manager
Canaan Management, Inc.
By: /s/ Brenton K. Ahrens, Vice President
-----------------------------------------
Chief Financial Officer and Treasurer
(MM) (NASDAQ:DRTX)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
(MM) (NASDAQ:DRTX)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
Más de Durata Therapeutics, Inc. Artículos de Noticias